Pfizer, Nvidia to help start-ups under S'pore-backed programme

Chipmaker Nvidia is linking up with US biopharmaceutical firm Pfizer and Singapore organisations to help global healthcare start-ups looking to expand in South-east Asia.

- Claire Huang Senior Business Correspondent

The two-year partnership will focus on creating new drugs through artificial intelligence (AI) and machine-learning tools.

The tools can shorten development periods, analyse large amounts of raw data and provide quicker insights for these emerging businesses.

It is hoped that this, in turn, will foster the development of ground-breaking therapies, patient care and services, and advance precision medicine.

The programme also aims to use AI to match different parties, such as government, universities and accelerators in the region.